首页> 外国专利> USE OF AT LEAST ONE P75NTR RECEPTOR INHIBITOR, ALONE OR IN ASSOCIATION WITH AT LEAST ONE TRKA RECEPTOR ACTIVATOR, OR OF AT LEAST ONE TRKA RECEPTOR ACTIVATOR, FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES

USE OF AT LEAST ONE P75NTR RECEPTOR INHIBITOR, ALONE OR IN ASSOCIATION WITH AT LEAST ONE TRKA RECEPTOR ACTIVATOR, OR OF AT LEAST ONE TRKA RECEPTOR ACTIVATOR, FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES

机译:单独使用至少一种P75NTR受体抑制剂或与至少一种TRKA受体激活剂或至少一种TRKA受体激活剂联合使用,以治疗慢性炎症性疾病

摘要

The present invention concerns the use of at least one p75NTR receptor inhibitor, alone or in association with at least one TrkA receptor activator, or at least one TrkA receptor activator, for the treatment of chronic inflammatory diseases as, for example, rheumatoid arthritis, juvenile idiopathic arthritis, psoriasis, multiple sclerosis, intestinal chronic inflammatory diseases, Lupus Erythematosus.
机译:本发明涉及至少一种p75NTR受体抑制剂单独或与至少一种TrkA受体激活剂或至少一种TrkA受体激活剂结合用于治疗慢性炎性疾病如类风湿性关节炎,青少年的用途特发性关节炎,牛皮癣,多发性硬化症,肠道慢性炎性疾病,红斑狼疮。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号